Middle East News Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East News Watch.

Press releases published on May 13, 2026

May 13, 2026

Polyrizon Advances Towards Human Clinical Trials: Secures First U.S. Clinical Site for NASARIX™ Allergy Blocker Clinical Trial

Indeterminate GlobeNewswire

May 13, 2026

Onconetix Reports Q1 2026 Progress at Proteomedix AG, Including Two New Peer-Reviewed Publications and Initiation of U.S. Validation Study

Indeterminate GlobeNewswire

May 13, 2026

Sweet Security Launches Sweet Attack to Debunk The Myth Before Mythos Ships

Indeterminate GlobeNewswire

May 13, 2026

Biofrontera Launches Second Annual “Hats On” Campaign to Raise Awareness of Actinic Keratosis

Indeterminate GlobeNewswire

May 13, 2026

ParaZero Demonstrates Advanced Counter Drone Solution at BSDA Exhibition in Romania for NATO Officials and Military Leadership

Indeterminate GlobeNewswire

May 13, 2026

Rectify Pharmaceuticals to Present Preclinical Data on New Dual Targeted ABCB4/BSEP Positive Functional Modulator at EASL 2026

Indeterminate GlobeNewswire

May 13, 2026

Fate Therapeutics Reports First Quarter 2026 Financial Results and Business Updates

Indeterminate GlobeNewswire

May 13, 2026

Lite Strategy Reports Fiscal 2026 Third Quarter Results

Indeterminate GlobeNewswire

May 13, 2026

Globex Options Carp Fluorspar Property in Nevada to Evion Group NL of Australia

Indeterminate GlobeNewswire

May 13, 2026

Silexion Therapeutics Announces Initiation of GMP Clinical Supply Manufacturing of SIL204 with Leading Global CDMO, and New Approval of Phase 2/3 Trial From Tel Aviv Sourasky Medical Center

Indeterminate GlobeNewswire

May 13, 2026

Century Therapeutics Reports First Quarter Financial Results and Business Updates 

Indeterminate GlobeNewswire

May 13, 2026

ORYZON to Present Updated Positive Clinical Data for Iadademstat in Acute Myeloid Leukemia at EHA 2026

Indeterminate GlobeNewswire

May 13, 2026

ZUSDURI Median Duration of Response Still Not Reached with 64.5% 36-month Duration of Response in the Pivotal ENVISION Trial

Indeterminate GlobeNewswire

May 13, 2026

Sapu Nano Announces First Patient Dosed in Phase 1b Trial of Sapu003, an Intravenous Deciparticle™ Formulation of Everolimus

Indeterminate GlobeNewswire

May 13, 2026

Sapu Nano 宣布 Sapu003 (基于 Deciparticle™ 技术的依维莫司静脉注射剂型) 1b 期临床试验完成首例患者给药

Indeterminate GlobeNewswire

May 13, 2026

Sapu Nano 宣佈旗下靜脈注射 Deciparticle™ 配方依維莫司 —— Sapu003 的 1b 期試驗，已為首位患者完成給藥

Indeterminate GlobeNewswire

May 13, 2026

Nexxen Reports Record First Quarter 2026 Financial Results

Indeterminate GlobeNewswire

May 13, 2026

Nexxen TV Home Screen Expands with TCL FFALCON and TiVo Ads

Indeterminate GlobeNewswire

May 13, 2026

BrainsWay Reports First Quarter 2026 Financial Results and Operational Highlights

Indeterminate GlobeNewswire

May 13, 2026

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire